
Proceedings of the Second Artificial Intelligence in Primary Immunodeficiencies (AIPI) Meeting.
AI in Primary Immunodeficiencies: Key Insights from AIPI Meeting π€π
Discover the newest research about AI innovations in π Allergy & Immunology.
AI in Primary Immunodeficiencies: Key Insights from AIPI Meeting π€π
AI enhances T-cell immunotherapy and vaccine development, improving predictions of T cell responses. π€π
Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. ππ«
NHS App now allows access to at-home health test results from MyHealthChecked. Patients can share results with healthcare professionals. ππ©Έ
NHS launches an image library to reduce misdiagnosis in diverse skin tones. Over 3,000 images available for healthcare professionals. πΈπ
Childhood asthma biomarkers identified: 4 key NET-related genes (FCGR2B, FCRL5, CCR2, FCRL1) linked to immune response. π¬οΈπ§¬
AI in allergy care: Enhancing patient education, but raises ethical concerns on autonomy and clinical reasoning. π€βοΈ
Emerging peptide technologies revolutionize medicine, food, and cosmetics. AI accelerates discovery, enhancing stability and efficacy. ππ½οΈπ
Immunomodulatory therapy for non-infectious uveitis: addressing gaps, optimizing strategies, and future AI advancements. π§ ποΈ
Coreline Soft secures AI imaging contracts with NHS and Boehringer Ingelheim, enhancing medical image analysis in healthcare. π₯π